OpenVSafe by OpenVAERS
Search V-safe

9X6-18511-80866

3 vaccinations 2 coded responses 15 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
109 / NY
Registered
2021-08-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-07-28
    Dose 1 — Pfizer-BioNTech
  2. 2021-08-18
    Registered in v-safe
  3. 2021-08-18
    Dose 2 — Pfizer-BioNTech
  4. 2021-08-18
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  5. 2021-08-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work or attend school
    Adult check-in
  6. 2021-08-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Nausea
    Adult check-in
  7. 2021-08-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-08-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-08-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-08-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-08-25
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-09-01
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-09-08
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-09-22
    Survey response — day 35, dose 2
    MedDRA: Nasopharyngitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Head cold
    MedDRA releases: 2024-11 · check-in free text available
  15. 2021-09-22
    Report sent to call center — day 35, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  16. 2021-09-23
  17. 2021-09-23
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  18. 2021-09-29
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-11-17
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2022-02-16
    Dose 3 — Pfizer-BioNTech
  21. 2022-02-18
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  22. 2022-05-18
    Survey response — 3 months, dose 3
    MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Covid
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-07-28Pfizer-BioNTech No
22021-08-18Pfizer-BioNTech No
32022-02-16Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 9 — day 35, dose 2

2021-09-22

Symptoms: Head cold

Release 11 — 3 months, dose 3

2022-05-18

Symptoms: Covid

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDNasopharyngitis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…